- Home
- NEWT vs RVNC Comparison
NEWT vs RVNC Comparison
Compare NEWT & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEWT
- RVNC
- Stock Information
- Founded
- NEWT 1998
- RVNC 1999
- Country
- NEWT United States
- RVNC United States
- Employees
- NEWT N/A
- RVNC N/A
- Industry
- NEWT Major Banks
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- NEWT Finance
- RVNC Health Care
- Exchange
- NEWT Nasdaq
- RVNC Nasdaq
- Market Cap
- NEWT 342.5M
- RVNC 546.4M
- IPO Year
- NEWT N/A
- RVNC 2014
- Fundamental
- Price
- NEWT $13.53
- RVNC $5.29
- Analyst Decision
- NEWT Hold
- RVNC Buy
- Analyst Count
- NEWT 3
- RVNC 10
- Target Price
- NEWT $12.33
- RVNC $10.86
- AVG Volume (30 Days)
- NEWT 158.0K
- RVNC 1.3M
- Earning Date
- NEWT 11-06-2024
- RVNC 11-06-2024
- Dividend Yield
- NEWT 5.61%
- RVNC N/A
- EPS Growth
- NEWT 18.20
- RVNC N/A
- EPS
- NEWT 1.66
- RVNC N/A
- Revenue
- NEWT $301,043,000.00
- RVNC $251,178,000.00
- Revenue This Year
- NEWT N/A
- RVNC $20.36
- Revenue Next Year
- NEWT $6.30
- RVNC $31.66
- P/E Ratio
- NEWT $8.10
- RVNC N/A
- Revenue Growth
- NEWT 54.13
- RVNC 40.23
- 52 Week Low
- NEWT $10.07
- RVNC $2.30
- 52 Week High
- NEWT $15.75
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- NEWT 65.25
- RVNC 44.50
- Support Level
- NEWT $12.34
- RVNC $5.10
- Resistance Level
- NEWT $13.85
- RVNC $5.43
- Average True Range (ATR)
- NEWT 0.34
- RVNC 0.17
- MACD
- NEWT 0.10
- RVNC 0.02
- Stochastic Oscillator
- NEWT 82.89
- RVNC 66.67
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.